coronavirus

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

  • by

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has… Read More »EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

  • by

Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health… Read More »What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

COVID-19 Pandemic-Related Excess Mortality and Potential Years of Life Lost in the U.S. and Peer Countries

  • by

A new issue brief reviews excess death rates in the U.S. and peer countries by age groups to examine how the pandemic has affected excess mortality rate among younger people. The analysis looks specifically at the excess deaths that arose in 2020 to examine how… Read More »COVID-19 Pandemic-Related Excess Mortality and Potential Years of Life Lost in the U.S. and Peer Countries

Compared to Peer Countries, the U.S. Had the Highest Rate of Mortality Among People Under Age 65 and Potential Years of Life Lost in 2020 due to the Pandemic

  • by

A new KFF issue brief examines 2020 data on excess mortality – the number of deaths above what is expected in a typical year – and finds that among similarly large and wealthy nations, the United States had the highest premature excess mortality rate in… Read More »Compared to Peer Countries, the U.S. Had the Highest Rate of Mortality Among People Under Age 65 and Potential Years of Life Lost in 2020 due to the Pandemic

How Doctors and Hospitals Can Help Defeat COVID-19 Vaccine Resistance and Misinformation

  • by

There’s a recent rise in national optimism that says—maybe—we have turned the corner on the pandemic lockdown. Admittedly, it’s been a tough year for nearly everyone, but miraculous vaccines and declining death rates have stirred newfound optimism. COVID-19 PUBLIC EDUCATION CAMPAIGN by the U.S. Department… Read More »How Doctors and Hospitals Can Help Defeat COVID-19 Vaccine Resistance and Misinformation

A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay

  • by

Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine,… Read More »A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay

Medicines watchdog says no decision made AstraZeneca jab for under-30s

  • by

Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca… Read More »Medicines watchdog says no decision made AstraZeneca jab for under-30s

The world’s poorest countries are at India’s mercy for vaccines. It’s unsustainable | Achal Prabhala and Leena Menghaney

  • by

This is what happens when a third of humanity depends on one manufacturer for Covid jabs. We need to waive patents now As the UK’s vaccination programme was “knocked off course” due to a delay in receiving five million doses of the AstraZeneca vaccine from… Read More »The world’s poorest countries are at India’s mercy for vaccines. It’s unsustainable | Achal Prabhala and Leena Menghaney

Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink

  • by

Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to… Read More »Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

  • by

Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine… Read More »AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

  • by

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine… Read More »AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

  • by

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine… Read More »AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

  • by

As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of… Read More »A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

The Impact of the COVID-19 Pandemic on LGBT People

  • by

This analysis examines the reported experiences among self-identified LGBT individuals based two months of KFF COVID-19 Vaccine Monitor reports and finds that LGBT people have experienced the COVID-19 pandemic differently than non-LGBT people, including being harder hit in some areas.

Updated KFF Calculator Estimates Marketplace Premiums to Reflect Expanded Tax Credits in COVID-19 Relief Legislation

  • by

KFF has updated its 2021 Health Insurance Marketplace Calculator to reflect the expanded premium tax credits available to people who purchase their own coverage through their state’s health insurance exchange as passed by Congress in the American Rescue Plan Act and expected to be signed… Read More »Updated KFF Calculator Estimates Marketplace Premiums to Reflect Expanded Tax Credits in COVID-19 Relief Legislation

How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?

  • by

This brief reviews information available through state websites and publicly available vaccine distribution plans to provide greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting. It provides a snapshot and examples… Read More »How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

  • by

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering… Read More »At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information

  • by

Many Relied on Another Person’s Help to Try to Get a Vaccine Appointment As many states and local authorities ramp up their COVID-19 vaccination efforts, the latest KFF COVID-19 Vaccine Monitor report provides the first in-depth look at Americans’ experiences trying to gather relevant information… Read More »KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information

ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines

  • by

Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have made unprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have… Read More »ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines

How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

  • by

Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other supplies and increasing manufacturing capacity to get COVID-19 vaccine shots in as many arms as possible. Even… Read More »How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

KFF Tracking Poll: More Than a Third of Americans Say They’ve Struggled to Pay Living Expenses Since December; 6 in 10 Families Hit by COVID Have Lost A Job or Income

  • by

Majorities Favor Provisions to Expand Marketplace Tax Credits and Encourage States to Expand Medicaid As Congress considers an additional $1.9 trillion COVID-19 relief plan, more than a third (37%) of Americans say that someone in their household has had trouble paying basic living expenses over… Read More »KFF Tracking Poll: More Than a Third of Americans Say They’ve Struggled to Pay Living Expenses Since December; 6 in 10 Families Hit by COVID Have Lost A Job or Income

KFF Health Tracking Poll: Economic Hardship, Health Coverage, And The ACA

  • by

This poll examines the public’s assessments of the Biden administration’s handling of the coronavirus pandemic, the impact COVID-19 has had on people’s finances, and support for provisions of the latest COVID-19 relief bill. It examines the public’s views of the ACA and possible next steps.

Most Americans Now Say They’ve Gotten At Least One Dose of a COVID-19 Vaccine or Want to Get Vaccinated As Soon As Possible, with Enthusiasm Rising Across Racial, Ethnic and Partisan Groups

  • by

While Enthusiasm Rises, a Persistent Minority Say They Definitely Will Not Get Vaccinated; Republicans, Rural Residents, and Essential Workers Outside Health Care Are Most Reluctant Groups More than half of Americans (55%) now say they want to get vaccinated as soon as possible (37%) or… Read More »Most Americans Now Say They’ve Gotten At Least One Dose of a COVID-19 Vaccine or Want to Get Vaccinated As Soon As Possible, with Enthusiasm Rising Across Racial, Ethnic and Partisan Groups

AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report

  • by

Expected shortfall of 90m doses could hit the EU’s ability to meet its target of vaccinating 70% of adults by summer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has told the European Union it expects to deliver less than half the Covid-19… Read More »AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report

Fighting variants of COVID-19

  • by

As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two vaccines have been granted Emergency Use Authorization (EUA) in the United States by the U.S. Food… Read More »Fighting variants of COVID-19

German politicians counter AstraZeneca vaccine scepticism with show of support

  • by

Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our coronavirus coverage Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed… Read More »German politicians counter AstraZeneca vaccine scepticism with show of support

New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity

  • by

KFF has an updated analysis of state-reported data as of February 16, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity. New to the analysis are comparisons of vaccination rates in each racial/ethnic group based on state-reported data of total people who have received at… Read More »New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity

COVAX and the United States

  • by

This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX’s organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

Two New Analyses: House COVID-19 Relief Plan Would Temporarily Lower Marketplace Premiums for Millions and More than Offset Short-Term State Costs to Expand Their Medicaid Programs

  • by

The House COVID-19 relief proposal would temporarily lower what millions of Marketplace enrollees and uninsured potential enrollees would pay toward premiums and would provide states that have not expanded their Medicaid programs a financial boost that would more than offset their costs initially, two new… Read More »Two New Analyses: House COVID-19 Relief Plan Would Temporarily Lower Marketplace Premiums for Millions and More than Offset Short-Term State Costs to Expand Their Medicaid Programs

GSK expands coronavirus antibody tie-up to include potential flu therapies

  • by

GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The big UK pharma is already working with Vir on antibody therapies for coronaviruses, and already have the antibody VIR-7831 in clinical trials including… Read More »GSK expands coronavirus antibody tie-up to include potential flu therapies

The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

  • by

Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and cures. As our industry continues to expand vaccine production and deliver medicines to patients in need, reliable IP protections… Read More »The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine?

  • by

This brief examines how people to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and… Read More »KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine?

KFF COVID-19 Vaccine Monitor: In Their Own Words

  • by

This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,

Oxford Covid vaccine 10% effective against South African variant, study suggests

  • by

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have… Read More »Oxford Covid vaccine 10% effective against South African variant, study suggests